EndeavorRx

DEVICE3 trials

Sponsors

Children's National Research Institute, Akili Interactive Labs, Inc.

Conditions

ADHDAttention DeficitAttention DifficultiesCognitive Deficit in AttentionPediatric ALLPediatric Brain TumorPediatric CancerSickle Cell Disease

Unknown Phase

Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease

RecruitingNCT05099874

Children's National Research InstituteAttention Deficit, Cognitive Deficit in Attention, Sickle Cell Disease

Start: 2022-12-20End: 2025-12-31Target: 20Updated: 2025-01-10

Feasibility/Acceptability of Attentional-Control Training in Survivors

RecruitingNCT05528939

Children's National Research InstituteAttention Difficulties, Cognitive Deficit in Attention, Pediatric ALL +2

Start: 2023-06-14End: 2025-08-31Target: 50Updated: 2025-01-10

EndeavorRx® Prospective Product Registry (Expedition EndeavorRx)

Active, not recruitingNCT05991167

Akili Interactive Labs, Inc.ADHD

Start: 2022-06-01End: 2025-12-31Updated: 2024-06-27